Mr. Speaker, I am pleased to speak to the bill, which is aimed at protecting the Canadian pharmaceutical supply from bulk exports south of the border.
Canadians need to have a secure supply of the pharmaceuticals they need. This is not to say that we do not understand that the health care system south of the border leaves much to be improved. More than 50 million Americans have no health coverage. Many other Americans have substandard coverage in the sense that they think they are covered by health care insurance, but when they become ill, they find out their hospital stay or drug coverage is not there to protect them.
We understand the need. Americans have been facing very high drug prices. That is why Canadian pharmaceutical companies have been appealing to Americans who have been accessing bulk exports of Canadian pharmaceuticals.
We do not want to be locked into a path where the security of supply for export supercedes the security of supply for Canadians. When Canadians need pharmaceutical drugs, whether for catastrophic care, or for an epidemic or pandemic of some kind, we need a policy to ensure we have the security of drugs we need. While we recognize the situation of Americans, the bulk export of Canadian drugs is not the solution.
My colleague, who introduced the bill, has explained that there are many drawbacks to relying on Canadian bulk exports, such as the scarcity of some ingredients that limit the amount of supply needed for some drugs. Many of them are time dated, so they cannot be stockpiled in a warehouse somewhere in case they might be needed by our neighbour south of the border.
We know what happens in a time of scarcity. During the SARS crisis a few years ago in Toronto, there was a great deal of panic about the cause of the epidemic and a great concern about how people could protect themselves from the spread of this disease. In a situation like this there is always the danger of hoarding. People will do what they think is in their best interests to protect themselves and their families. Some people also hoard because they think they can make some business from this situation. If there is a crisis situation, we want to ensure that Canadians will have access to the drug supply they need.
We also know there have been problems with counterfeit medications. Our border inspectors do not inspect every shipment that goes across the border. I have heard that 1% of shipments are physically inspected. This then leaves open the possibility of counterfeiting, which not only endangers the health of Americans, it also diverts production that could be put to beneficial use rather than counterfeit use.
It is important to safeguard the Canadian supply and to avert going down the path where we open ourselves or our neighbours to the south to the risks of bulk drug exports. The Government of Canada must do what is necessary to ensure that Canadians are protected.
I also want to speak about drug coverage in Canada. While Americans may think we have a more desirable situation here, because of lower drug prices, primarily through generic brand pharmaceuticals, we also have a problem with drug prices on this side of the border.
The drug patent laws have been giving brand name pharmaceutical companies more and more patent protection over the years. The Conservative government extended patent protection up to eight years now for brand name drugs. This will see hundreds of millions more dollars of costs added to our pharmaceutical costs in Canada. We also have the problem of evergreening of drugs under patent protection, which has not been addressed.
What it means is higher drug costs for Canadians. They are so costly that in fact many Canadians simply cannot afford to have their prescriptions filled as it stands today. It adds to the financial stress that many Canadian families are under. We can all imagine the situation of people who go to a drug store to fill their prescriptions. They find out the price and they simply cannot afford to have the prescription filled, which would help them regain their health.
It is time Canada had a national universal drug plan to promote better health for Canadians without breaking the bank. We have an opportunity while we have surplus budgets, surplus funds federally, if the government does not give it all away to the banks and the oil companies, to invest in Canadians. We can pool our resources to bulk purchase drugs for Canadians. We could do that through a universal pharmaceutical program.
We have seen with our universal health care program, medicare, that our costs are far below costs south of the border, by pooling our resources and ensuring that everyone is covered, rather than leaving too many people behind.
The government has dropped its promise to deal with wait times when it comes to health care. That has been a shameful oversight. Here is an opportunity for the Conservatives to introduce something positive with respect to health care, and that is a national pharmacare program.
An important step is to secure our supply of drugs for Canadians and to ensure we do not export drugs south of the border that could jeopardize supply in Canada. I believe a more fundamental, an important step and a necessary step for Canadians is to ensure they all have access to the pharmaceutical drugs they need. We have to keep costs down as a country. I believe a national pharmacare program is long overdue. It would make a huge difference for Canadian families.